-
T7 RNA Polymerase for mRNA Workflows
2026-09-01
T7 RNA Polymerase converts promoter-bearing DNA into research-grade RNA for applications ranging from reporter assays to localized mRNA delivery studies. This guide connects reliable template preparation and reaction control with the p21 mRNA–LNP bladder cancer workflow reported in recent research.
-
Fluoxetine HCl: From Serotonin to Motivation
2026-09-01
Fluoxetine HCl is more than a serotonin transporter probe: it can help distinguish molecular serotonergic effects from motivation-specific behavioral phenotypes. This article translates developmental SSRI findings into better assay design, formulation control, and interpretation for neuroscience research.
-
Honokiol for Reliable Cell Response Assays
2026-08-31
Learn how Honokiol (SKU N1672) can support more interpretable cell viability, proliferation, and cytotoxicity workflows through controlled solvent handling, endpoint selection, and product qualification. This scenario-based guide connects Honokiol’s documented physicochemical properties and mechanisms with practical assay decisions.
-
Ceftolozane Sulfate: From MIC to PK/PD
2026-08-31
Ceftolozane sulfate research is most informative when MIC results are connected to time-dependent exposure and renal clearance. This article provides a translational framework for interpreting susceptibility data, selecting assay conditions, and using PK/PD evidence without confusing laboratory findings with clinical dosing advice.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-08-30
This fluorescent secondary antibody provides a practical route for detecting rabbit IgG primary antibodies in immunofluorescence, flow cytometry, immunohistochemistry, and fluorescence microscopy workflows. It should not be assumed to detect non-rabbit primaries or to provide validated quantitative multiplex performance without assay-specific controls and optimization.
-
Ceftolozane-Tazobactam in Nosocomial Pneumonia
2026-08-29
The reference study explains how ceftolozane-tazobactam combines a structurally optimized cephalosporin with a beta-lactamase inhibitor to address difficult nosocomial pneumonia pathogens, particularly multidrug-resistant Pseudomonas aeruginosa. Its synthesis of molecular, susceptibility, pharmacokinetic-pharmacodynamic, and clinical evidence provides a useful framework for interpreting resistance suppression and translating antimicrobial activity into infection-model design.
-
Hyaluronic Acid Sodium Salt: A Research Decision Guide
2026-08-28
Hyaluronic acid sodium salt is more than a passive matrix ingredient: its molecular weight, interfacial behavior, and formulation context can reshape assay interpretation. This guide connects Sodium hyaluronate biology with HA-coated siRNA research and practical experimental controls.
-
HOXC8, Caspase-1, and Pyroptosis in NSCLC
2026-08-28
A 2025 Cell Death and Disease study identifies HOXC8 as a transcriptional suppressor of CASP1 in non-small cell lung cancer. Its depletion increases caspase-1 abundance and triggers ASC-independent pyroptosis through a mechanism involving HDAC1/2 recruitment, offering a mechanistic framework for studying tumor-associated inflammatory cell death.
-
Clathrin-Mediated Entry of Type III GCRV
2026-08-27
Wang et al. used pharmacological inhibition, transmission electron microscopy, and real-time quantitative PCR to investigate how genotype III grass carp reovirus enters CIK cells. Their results support a dynamin-dependent, clathrin-mediated and endosomal pH-dependent entry route, while also showing that inhibitor responses can differ substantially between related acidification perturbants.
-
Z-WEHD-FMK in Caspase-1 Pyroptosis Research
2026-08-27
Z-WEHD-FMK provides a cell-permeable, irreversible way to interrogate caspase-1/4/5 activity in pyroptosis, inflammation, and pathogen-cell interactions. This guide connects HOXC8-regulated caspase-1 biology with practical NSCLC and Chlamydia workflows, including dosing, controls, and troubleshooting.
-
AT13387 as an Assay Design Lens for Hsp90 Research
2026-08-26
AT13387 is an orally bioavailable Hsp90 inhibitor for dissecting oncogenic signaling, cell cycle arrest, and apoptosis in cancer biology research. This article adds a distinct assay-design perspective by using recent NINJ1-mediated viral protein secretion findings to sharpen interpretation of cell death and extracellular-release readouts.
-
Oligo-dT Membranes for mRNA Capture Purification
2026-08-26
The reference study develops quantitative design rules for oligo-dT affinity membranes, showing that ligand accessibility, clustering, pore size, and ligand length can matter more than total ligand loading. Its local-density model and membrane experiments provide a practical framework for improving polyadenylated mRNA capture while reducing steric ligand wastage.
-
GSTA1 in α-Amanitin Hepatotoxicity
2026-08-25
The reference study identifies GSTA1 as an unexpected driver of α-amanitin liver injury rather than a purely protective detoxification enzyme. By combining mouse toxicology, multi-omics, molecular interaction assays, and genetic rescue experiments, it links NRF2-associated GSTA1 upregulation to glutathione depletion, reactive oxygen species accumulation, and hepatocyte death.
-
Uridine, Trisodium Salt in Cell Assays
2026-08-25
Learn how Uridine, Trisodium Salt (SKU B1473) can be incorporated into cell viability, proliferation, cytotoxicity, and RNA metabolism studies without obscuring assay interpretation. This scenario-driven guide covers controls, solubility, stock preparation, storage, data analysis, and practical supplier selection.
-
Exercise, Muscle EVs, and Microglial Aβ Clearance
2026-08-24
A 2026 Nature Aging study identifies skeletal muscle-derived extracellular vesicles as mediators of exercise-related benefits in Alzheimer’s disease mice. The work links swimming-induced vesicle release to microglial plaque clearance and implicates miR-378a-3p–dependent lipid-metabolism regulation as a potential exercise-mimicking therapeutic mechanism.